REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/08/2026
Back to search
Official data from USPTO
SYNBOT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SYNBOT
ST13
US500000079293510Class
1, 5, 9, 42, 44
Filing
79293510
Registration
6375285
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/09/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 9, 42, 44
Filing date
05/12/2020
Registration date
06/08/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2021
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
BULLOFF, TOBY ELLEN
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Synbionik GmbH
Representatives
Vani Moodley HM LAW GROUP LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry; biological preparations for use in industry and science; biological preparations for use in manufacture; biological preparations for use in science; biological preparation for use in cell cultures other than for medical or veterinary use; blood culture media being cell culture media for scientific use; biochemicalsnamely precursors for in vitro genetic engineering use; chemical preparations for use in DNA analysis for scientific and research purposes; enzymes for use as biochemical catalysts for scientific and research purposes; biochemicalsnamely polypeptides for in vitro research use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic reagents for scientific use; diagnostic test kits for use in sciencecomprised of patch preparations in the nature of diagnostic reagents; diagnostic test kits for scientific usecomprised of reagentsprocessing chemicals; biochemicals for in vitro and in vivo use in industry and science; molecular biological products in the nature of reagents for use in industry and science; plasmids for use in industry and science; chromosomes being DNA moleculesDNA polymerase for use in industry and science; Diagnostic test kits for use in sciencecomprised of patch preparations being diagnostic reagents
Class 5
Preparations for detecting genetic predispositions for medical purposes; biological implantsa vital processed human or animal connective tissue; biological boneskin tissue for implantation; biological adjuvants for medical purposes; biological reagents for medical use; biological preparations for the treatment of cancer; mixed biological preparations for medical purposes for the treatment of cancer and the prevention and treatment of infectious diseases; biological tissue cultures for medical purposes; bone growth media consisting of biological materials for medical purposes; human plasma protein being blood plasma; blood plasma; blood components being cord bloodbloodblood plasma for medical purposes; blood substitutes for humanveterinary use; blood protein fractions for medical purposesfor use in cell culture products and diagnostic applications; DNA synthesis inhibitors for medical use; chemical preparations for use in DNA analysis for medical purposes for the treatment of cancer and infectious diseases; cells for medical use; diagnostic medical reagents for medical use in diagnosing inflammatoryinfectionscentral nervous systemcardiovascularneurologicalendocrineautoimmune and genetic diseases and cancer; diagnostic test kits for use in diagnosing inflammatoryinfectiouscentral nervous systemcardiovascularneurological endocrineautoimmune and genetic diseases and cancercomprised of reagentsprocessing chemicals and transdermal patches; medical diagnostic test kits comprised of medical diagnostic reagents for detecting pathogens in the environment
Class 9
DNA microarrays; DNA chips; biochip sensors for research or scientific purposes; bioreactor for cell culturing; laboratory equipmentlaboratory apparatus and laboratory instruments for use in protein purificationDNA analysis and analysis of blood and biological tissue cultures; laboratory apparatus and instrumentsapparatus for sieve teststhe detection of analytes in samples and the identification of the sample typetogether with measurement pattern and kits for building and screening of molecular systemscomprised of DNA microarraysas well as parts for itresearch laboratory analyzers for measuringtesting and analyzing blood and other bodily fluidsurine analyzersimmunoassay analyzershematology analyzers
Class 42
Genetic research; genetic fingerprinting for scientific or medical research purposes; scientific research relating to genetics; scientific research in the field of genetics and genetic engineering; biological laboratory services; biological cloning services; biological researchclinical research and medical researchconducting clinical trials for others as well as medical and clinical research in the field of cancer and infectious diseases; scientific laboratory servicesservices of a chemical and/or biological laboratory; blood analysis services; genetic engineering services; DNA screening for scientific research purposes; research and development in the field of microorganisms and cells; scientific services relating to the isolation and cultivation of human tissues and cells; research and development services for third parties in the fields of diagnostic chemicalscompounds and devicesmeasuring apparatus for use in product research and developmentseparation and purification processesenvironmental testing processes and industrial quality control processes; chemical sieve analysis; scientific and technological servicesresearch and design services in the field of diagnostic chemicals; industrial analysis in the nature of analysis of industrial fluids; industrial research in the field of diagnostic chemicals; services of an industrial designer; quality control for others; authentication services in the field of diagnostic chemicalsmeasuring apparatus; design and development of computer hardware and software; scientific and product research in the area of textile dyes; productscientificbiomedical researchin the area of textile dyes consisting of bacteria
Class 44
Medical and health assessment services relating to naked DNAgenetics and genetic testing for medical purposes; genetic counselling; blood bank services; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical diagnostic services being the execution of tests and analysis; execution of medical tests for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/28/2021
FIMP
FINAL DISPOSITION PROCESSED
09/28/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/30/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/30/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/30/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/23/2021
PUBO
PUBLISHED FOR OPPOSITION
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/22/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
ALIE
ASSIGNED TO LIE
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/17/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/16/2021
RFNT
REFUSAL PROCESSED BY IB
11/02/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/15/2020
RFRR
REFUSAL PROCESSED BY MPU
10/15/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/23/2020
CNRT
NON-FINAL ACTION WRITTEN
09/22/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/22/2020
DOCK
ASSIGNED TO EXAMINER
09/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/18/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/17/2020
Continuous trademark protection
Get notified about every new filing that threatens SYNBOT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.